(MENAFN- UkrinForm)Ukraine expects to receive 20 million doses of the Pfizer-BioNTech vaccine in 2021, Minister of Health Maksym Stepanov has said.
''Due to the efforts of the Ministry of Health, with the full support of President Volodymyr Zelensky, we have managed to double the supplies of the Pfizer-BioNTech vaccine this calendar year. That is, instead of 10 million doses, we will receive 20 million doses of the Pfizer vaccine in 2021,” Stepanov said at a briefing, an Ukrinform correspondent reports.
According to Stepanov, in total, the Ministry of Health has contracted 42 million doses of vaccines to be delivered in 2021. This is 8 million doses of the COVID-19 vaccine under the COVAX Facility, 32 million doses under direct contracts between manufacturers and Ukraine. Of these, 20 million doses of the Pfizer-BioNTech vaccine, 10 million doses of the U.S. Novavax vaccine, which will be produced at the Serum Institute of India, the AstraZeneca vaccine under direct contracts and the COVAX Facility, and the Chinese Sinovac's CoronaVac vaccine.
Stepanov stressed that this amount of COVID-19 vaccines will be enough to vaccinate the majority of the adult population of Ukraine in 2021. However, according to the minister, the government intends to increase the supplies of coronavirus vaccines up to 48 million doses for the vaccination of 70% of the adult population of Ukraine
He reminded that the Ukraine and the Serum Institute of India reached an agreement to increase the supplies of COVID-19 vaccine from 10 to 15 million doses, as well as an agreement with Sinovac to increase the supply of CoronaVac vaccine.
iy
MENAFN11052021000193011044ID1102065289
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.